Mike Borowitz

View Scopus Profile

Research activity per year

309 Article
17 Letter
12 Review article
5 Comment/debate
More
- 3 Chapter
- 3 Editorial

5 results

Filter

2023
Correction: Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932 (Leukemia, (2023), 37, 6, (1375-1378), 10.1038/s41375-023-01870-8)
Schore, R. J., Angiolillo, A. L., Kairalla, J. A., Devidas, M., Rabin, K. R., Zweidler-McKay, P., Borowitz, M. J., Wood, B., Carroll, A. J., Heerema, N. A., Relling, M. V., Hitzler, J., Kadan-Lottick, N. S., Maloney, K., Wang, C., Carroll, W. L., Winick, N. J., Raetz, E. A., Loh, M. L. & Hunger, S. P., Jun 2023, In: Leukemia. 37, 6, p. 1406 1 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Duncavage, E. J., Bagg, A., Hasserjian, R. P., DiNardo, C. D., Godley, L. A., Iacobucci, I., Jaiswal, S., Malcovati, L., Vannucchi, A. M., Patel, K. P., Arber, D. A., Arcila, M. E., Bejar, R., Berliner, N., Borowitz, M. J., Branford, S., Brown, A. L., Cargo, C. A., Döhner, H. & Falini, B. & 24 others, Garcia-Manero, G., Haferlach, T., Hellström-Lindberg, E., Kim, A. S., Klco, J. M., Komrokji, R., Lee-Cheun Loh, M., Loghavi, S., Mullighan, C. G., Ogawa, S., Orazi, A., Papaemmanuil, E., Reiter, A., Ross, D. M., Savona, M., Shimamura, A., Skoda, R. C., Solé, F., Stone, R. M., Tefferi, A., Walter, M. J., Wu, D., Ebert, B. L. & Cazzola, M., Nov 24 2022, In: Blood. 140, 21, p. 2228-2247 20 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium
Ponte-di-Legno Consortium, Mar 24 2022, In: Blood. 139, 12, p. 1785-1793 9 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
2021
Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631 (Leukemia, (2021), 35, 5, (1279-1290), 10.1038/s41375-021-01177-6)
Brown, P. A., Kairalla, J. A., Hilden, J. M., Dreyer, Z. A. E., Carroll, A. J., Heerema, N. A., Wang, C., Devidas, M., Gore, L., Salzer, W. L., Winick, N. J., Carroll, W. L., Raetz, E. A., Borowitz, M. J., Small, D., Loh, M. L. & Hunger, S. P., May 2021, In: Leukemia. 35, 5, p. 1527 1 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
2018

Syphilitic lymphadenitis with abscess formation involving cervical lymph nodes
Duffield, A. S. & Borowitz, M. J., Feb 8 2018, In: Blood. 131, 6, p. 707 1 p.
Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Mike Borowitz

Research output

Search results

Correction: Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932 (Leukemia, (2023), 37, 6, (1375-1378), 10.1038/s41375-023-01870-8)

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium

Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631 (Leukemia, (2021), 35, 5, (1279-1290), 10.1038/s41375-021-01177-6)

Syphilitic lymphadenitis with abscess formation involving cervical lymph nodes